{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:13:36Z","timestamp":1793283216163,"version":"4.5.0"},"reference-count":22,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Hosp Pharm"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>Background: The American Heart Association has a call to action to reduce hospital acquired venous thromboembolism (HA-VTE) by 20% by the year 2030. There is increasing recognition that quality improvement initiatives for VTE reduction should focus on reducing potentially preventable HA-VTE. The objective of our study was to determine what proportion of HA-VTE events are potentially preventable. Methods: This was a retrospective, single center pilot study of 50 patients with HA-VTE. Seven preventability factors were identified with a focus on VTE prescription and administration. Data were extracted through chart review using a systematic data collection form. The primary endpoint was the proportion of patients with potentially preventable HA-VTE. Descriptive statistics were used. Results: The median age was 66\u2009years with an admission VTE risk level of moderate-high in 94%. Potentially preventable HA-VTE was found in 40% of cases. Missed doses occurred in 29.8% with a median of 2 missed doses and a range of 1 to 20. Patient refusal was the most common reason for missed doses in 71%. Delays in initiation occurred in 12.7%. Sixty percent of those on mechanical prophylaxis only had nonadherence. Conclusion: Forty percent of HA-VTE cases were potentially preventable. Missed doses was the most common preventability factor identified with patient refusal accounting for most missed doses.<\/jats:p>","DOI":"10.1177\/00185787231198164","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T05:33:49Z","timestamp":1694410429000},"page":"183-187","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Hospital Acquired Venous Thromboembolism: A Preventability Assessment"],"prefix":"10.1177","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5978-3770","authenticated-orcid":false,"given":"Maureen A.","family":"Smythe","sequence":"first","affiliation":[{"name":"Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA"},{"name":"Wayne State University, Detroit, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Koerber","sequence":"additional","affiliation":[{"name":"Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA"},{"name":"Wayne State University, Detroit, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Roberts","sequence":"additional","affiliation":[{"name":"Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA"},{"name":"Henry Ford Macomb Hospital, Clinton Township, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA"},{"name":"Wayne State University, Detroit, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Batke","sequence":"additional","affiliation":[{"name":"Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"bibr1-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000769"},{"key":"bibr2-00185787231198164","unstructured":"Centers for Disease Control and Prevention. CDC 24\/7 saving lives, protecting people\n                      \u2122\n                      , venous thromboembolism (blood clots). Accessed June 13, 2023. Data and Statistics on HA-VTE | CDC."},{"key":"bibr3-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.14.1868"},{"key":"bibr4-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.026897"},{"key":"bibr5-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000000966"},{"key":"bibr6-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15600"},{"key":"bibr7-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.6.1964"},{"key":"bibr8-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X14543737"},{"key":"bibr9-00185787231198164","unstructured":"AHRQuality indicators. Accessed June 13, 2023. https:\/\/qualityindicators.ahrq.gov\/measures\/psi_resources."},{"key":"bibr10-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018022954"},{"key":"bibr11-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000975"},{"key":"bibr12-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1177\/1062860618808378"},{"key":"bibr13-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2020-000643"},{"key":"bibr14-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2013.3963"},{"key":"bibr15-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2657"},{"key":"bibr16-00185787231198164","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3290"},{"key":"bibr17-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181664"},{"key":"bibr18-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.4741"},{"key":"bibr19-00185787231198164","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2282"},{"key":"bibr20-00185787231198164","unstructured":"AC forum rapid resource, venous thromboembolism (VTE) prophylaxis in acutely ill medical patients. Accessed June 13, 2023. https:\/\/acforum-excellence.org\/Resource-Center\/resource_files\/1702-2021-03-03-142440.pdf."},{"key":"bibr21-00185787231198164","unstructured":"Thrombosis Canada, clinical guidelines. Accessed June 13, 2023. https:\/\/thrombosiscanada.ca\/clinicalguides\/#."},{"key":"bibr22-00185787231198164","unstructured":"Specifications manual for the Joint Commission National Quality Measures (v2023B), Accessed June 13, 2023. VTE-6 (v2023B) (jointcommission.org)."}],"container-title":["Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787231198164","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00185787231198164","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787231198164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:40:24Z","timestamp":1777452024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00185787231198164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1177\/00185787231198164"],"URL":"https:\/\/doi.org\/10.1177\/00185787231198164","relation":{},"ISSN":["0018-5787","1945-1253"],"issn-type":[{"value":"0018-5787","type":"print"},{"value":"1945-1253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,11]]}}}